BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17868650)

  • 21. Exogenous fibroblast growth factor-2 induces a transformed phenotype in vascular kaposi's sarcoma-like cells.
    Cavallaro U; Soria MR; Montesano R
    Mol Cell Biol Res Commun; 2000 Oct; 4(4):203-5. PubMed ID: 11409912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of AIDS-associated Kaposi's sarcoma.
    Ensoli B; Barillari G; Gallo RC
    Hematol Oncol Clin North Am; 1991 Apr; 5(2):281-95. PubMed ID: 2022594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma.
    Ensoli B; Gendelman R; Markham P; Fiorelli V; Colombini S; Raffeld M; Cafaro A; Chang HK; Brady JN; Gallo RC
    Nature; 1994 Oct; 371(6499):674-80. PubMed ID: 7935812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus transactivator protein (Tat) stimulates chemotaxis, calcium mobilization, and activation of human polymorphonuclear leukocytes: implications for Tat-mediated pathogenesis.
    Benelli R; Barbero A; Ferrini S; Scapini P; Cassatella M; Bussolino F; Tacchetti C; Noonan DM; Albini A
    J Infect Dis; 2000 Dec; 182(6):1643-51. PubMed ID: 11069235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis.
    Fiorelli V; Barillari G; Toschi E; Sgadari C; Monini P; Stürzl M; Ensoli B
    J Immunol; 1999 Jan; 162(2):1165-70. PubMed ID: 9916748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential response to Tat and FGF-2 of two novel clonal populations derived from murine Kaposi-like lesions developing in Tat transgenic mice.
    Wu Z; Mariotti M; Cavallaro U; Soria MR; Maier JA
    Microvasc Res; 2002 Jan; 63(1):19-26. PubMed ID: 11749069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of HIV-1 Tat peptides for future therapeutic angiogenesis.
    Ismail M; Henklein P; Huang X; Braumann C; Rückert RI; Dubiel W
    Eur J Haematol; 2006 Aug; 77(2):157-65. PubMed ID: 16800839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis.
    Barillari G; Buonaguro L; Fiorelli V; Hoffman J; Michaels F; Gallo RC; Ensoli B
    J Immunol; 1992 Dec; 149(11):3727-34. PubMed ID: 1431144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
    Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
    Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness.
    Thompson EW; Nakamura S; Shima TB; Melchiori A; Martin GR; Salahuddin SZ; Gallo RC; Albini A
    Cancer Res; 1991 May; 51(10):2670-6. PubMed ID: 2021945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits T cell apoptosis by combating oxidative damage of mitochondria.
    Miao B; Li J; Fu X; Gan L; Xin X; Geng M
    Mol Pharmacol; 2005 Dec; 68(6):1716-27. PubMed ID: 16141310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells.
    Albini A; Soldi R; Giunciuglio D; Giraudo E; Benelli R; Primo L; Noonan D; Salio M; Camussi G; Rockl W; Bussolino F
    Nat Med; 1996 Dec; 2(12):1371-5. PubMed ID: 8946838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.
    Sgadari C; Barillari G; Toschi E; Carlei D; Bacigalupo I; Baccarini S; Palladino C; Leone P; Bugarini R; Malavasi L; Cafaro A; Falchi M; Valdembri D; Rezza G; Bussolino F; Monini P; Ensoli B
    Nat Med; 2002 Mar; 8(3):225-32. PubMed ID: 11875492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 Tat increases the adhesion of monocytes and T-cells to the endothelium in vitro and in vivo: implications for AIDS-associated vasculopathy.
    Matzen K; Dirkx AE; oude Egbrink MG; Speth C; Götte M; Ascherl G; Grimm T; Griffioen AW; Stürzl M
    Virus Res; 2004 Sep; 104(2):145-55. PubMed ID: 15246652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of human immunodeficiency virus-I in the pathogenesis of acquired immunodeficiency syndrome-related Kaposi's sarcoma: the importance of an inflammatory and angiogenic milieu.
    Dezube BJ
    Semin Oncol; 2000 Aug; 27(4):420-3. PubMed ID: 10950368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological assays and genomic analysis reveal lipoic acid modulation of endothelial cell behavior and gene expression.
    Larghero P; Venè R; Minghelli S; Travaini G; Morini M; Ferrari N; Pfeffer U; Noonan DM; Albini A; Benelli R
    Carcinogenesis; 2007 May; 28(5):1008-20. PubMed ID: 17127716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts.
    Samaniego F; Young D; Grimes C; Prospero V; Christofidou-Solomidou M; DeLisser HM; Prakash O; Sahin AA; Wang S
    Cell Growth Differ; 2002 Aug; 13(8):387-95. PubMed ID: 12193477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate.
    Dell'Eva R; Pfeffer U; Vené R; Anfosso L; Forlani A; Albini A; Efferth T
    Biochem Pharmacol; 2004 Dec; 68(12):2359-66. PubMed ID: 15548382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-angiogenic cues from vascular basement membrane collagen.
    Colorado PC; Torre A; Kamphaus G; Maeshima Y; Hopfer H; Takahashi K; Volk R; Zamborsky ED; Herman S; Sarkar PK; Ericksen MB; Dhanabal M; Simons M; Post M; Kufe DW; Weichselbaum RR; Sukhatme VP; Kalluri R
    Cancer Res; 2000 May; 60(9):2520-6. PubMed ID: 10811134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiostatin inhibits extracellular HIV-Tat-induced inflammatory angiogenesis.
    Benelli R; Morini M; Brigati C; Noonan DM; Albini A
    Int J Oncol; 2003 Jan; 22(1):87-91. PubMed ID: 12469189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.